Home Health Covid: J&J will ask the EMA for the authorization for the double dose – Healthcare

Covid: J&J will ask the EMA for the authorization for the double dose – Healthcare

by admin

Clinical trials on the Johnson & Johnson (Janssen) vaccine have shown 100% efficacy against severe Covid-19 after two doses and 75% after a single dose. Johnson & Johnson (J&J) makes it known in a note. The company therefore communicated its intention to submit to the European Medicines Agency (EMA) the authorization request for a complete package that includes the single dose plus a booster dose. The J&J vaccine is currently licensed as a single dose.

breaking latest news © Copyright ANSA


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy